40
Participants
Start Date
July 20, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
CD19-CAR-T Cells
T cells purified from the PBMC of subjects or subjects' relatives which depends on their conditions, transduced with 4-1BB/CD3-ζ lentiviral vector, expanded in vitro for future administration.
RECRUITING
Hebei Yanda Ludaopei Hospital, Langfang
Lead Sponsor
Bioceltech Therapeutics, Ltd.
INDUSTRY